Myxofibrosarcoma landscape: diagnostic pitfalls, clinical management and future perspectives

Myxofibrosarcoma landscape: diagnostic pitfalls, clinical management and future perspectives

Myxofibrosarcoma (MFS) is a common entity of adult soft tissue sarcomas (STS) characterized by a predilection of the extremities and a high local recurrence rate. Originally classified as a myxoid variant of malignant fibrous histiocytoma, this musculoskeletal tumor has been recognized since 2002 as...

Full description

Bibliographic Details
Main Authors:	Silvia Vanni, Alessandro De Vita, Lorena Gurrieri, Valentina Fausti, Giacomo Miserocchi, Chiara Spadazzi, Chiara Liverani, Claudia Cocchi, Chiara Calabrese, Alberto Bongiovanni, Nada Riva, Laura Mercatali, Federica Pieri, Roberto Casadei, Enrico Lucarelli, Toni Ibrahim
Format:	Article
Language:	English
Published:	SAGE Publishing 2022-06-01
Series:	Therapeutic Advances in Medical Oncology
Online Access:	https://doi.org/10.1177/17588359221093973

Similar Items

Characterization and Drug Sensitivity of a New High-Grade Myxofibrosarcoma Cell Line
by: Giacomo Miserocchi, et al.
Published: (2018-10-01)

Myxofibrosarcoma primary cultures: molecular and pharmacological profile
by: Alessandro De Vita, et al.
Published: (2017-12-01)

A Rationale for the Activity of Bone Target Therapy and Tyrosine Kinase Inhibitor Combination in Giant Cell Tumor of Bone and Desmoplastic Fibroma: Translational Evidences
by: Alessandro De Vita, et al.
Published: (2022-02-01)

The emerging role of cancer nanotechnology in the panorama of sarcoma
by: Laura Mercatali, et al.
Published: (2022-10-01)

Modeling Myxofibrosarcoma: Where Do We Stand and What Is Missing?
by: Enrico Lucarelli, et al.
Published: (2023-10-01)

Unveiling the Genomic Basis of Chemosensitivity in Sarcomas of the Extremities: An Integrated Approach for an Unmet Clinical Need
by: Silvia Vanni, et al.
Published: (2023-04-01)

mTOR inhibitor and bone-targeted drugs break the vicious cycle between clear-cell renal carcinoma and osteoclasts in an in vitro co-culture model
by: Chiara Spadazzi, et al.
Published: (2019-06-01)

Case Report: Adult NTRK-Rearranged Spindle Cell Neoplasm: Early Tumor Shrinkage in a Case With Bone and Visceral Metastases Treated With Targeted Therapy
by: Federica Recine, et al.
Published: (2022-01-01)

Management and potentialities of primary cancer cultures in preclinical and translational studies
by: Giacomo Miserocchi, et al.
Published: (2017-11-01)

Metastatic neuroendocrine neoplasia treatments in patients over 70 years of age
by: Alberto Bongiovanni, et al.
Published: (2018-12-01)

Phase-II Trials of Pazopanib in Metastatic Neuroendocrine Neoplasia (mNEN): A Systematic Review and Meta-Analysis
by: Alberto Bongiovanni, et al.
Published: (2020-04-01)

Activity of Eribulin in a Primary Culture of Well-Differentiated/Dedifferentiated Adipocytic Sarcoma
by: Alessandro De Vita, et al.
Published: (2016-12-01)

Deciphering the Genomic Landscape and Pharmacological Profile of Uncommon Entities of Adult Rhabdomyosarcomas
by: Alessandro De Vita, et al.
Published: (2021-10-01)

HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumors
by: Chiara Liverani, et al.
Published: (2023-01-01)

A novel patient-derived immortalised cell line of myxofibrosarcoma: a tool for preclinical drugs testing and the generation of near-patient models
by: Ania Naila Guerrieri, et al.
Published: (2023-12-01)

Precision Medicine in Head and Neck Cancers: Genomic and Preclinical Approaches
by: Giacomo Miserocchi, et al.
Published: (2022-05-01)

Three-dimensional collagen-based scaffold model to study the microenvironment and drug-resistance mechanisms of oropharyngeal squamous cell carcinomas
by: Giacomo Miserocchi, et al.
Published: (2021-05-01)

Myxofibrosarcoma: a diagnostic pitfall
by: Charlotte Castronovo, et al.
Published: (2013-05-01)

Lysyl oxidase engineered lipid nanovesicles for the treatment of triple negative breast cancer
by: Alessandro De Vita, et al.
Published: (2021-03-01)

Lineage‐specific mechanisms and drivers of breast cancer chemoresistance revealed by 3D biomimetic culture
by: Chiara Liverani, et al.
Published: (2022-02-01)

High-grade transformation of a polymorphous adenocarcinoma of the salivary gland: a case report and review of the literature
by: Giacomo Miserocchi, et al.
Published: (2023-09-01)

Systemic Inflammatory Indices in Second-Line Soft Tissue Sarcoma Patients: Focus on Lymphocyte/Monocyte Ratio and Trabectedin
by: Valentina Fausti, et al.
Published: (2023-02-01)

Combining preclinical tools and models to unravel tumor complexity: Jump into the next dimension
by: Giacomo Miserocchi, et al.
Published: (2023-03-01)

Recurrent neck myxofibrosarcoma: a case report
by: Chiara Pagnoni, et al.
Published: (2021-10-01)

Paratesticular myxofibrosarcoma
by: Sirin Baspinar, et al.
Published: (2014-01-01)

Activity and Safety of Immune Checkpoint Inhibitors in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis
by: Alberto Bongiovanni, et al.
Published: (2021-05-01)

Immune Checkpoint Inhibitors With or Without Bone-Targeted Therapy in NSCLC Patients With Bone Metastases and Prognostic Significance of Neutrophil-to-Lymphocyte Ratio
by: Alberto Bongiovanni, et al.
Published: (2021-11-01)

Prognostic and Predictive Role of Body Composition in Metastatic Neuroendocrine Tumor Patients Treated with Everolimus: A Real-World Data Analysis
by: Nicoletta Ranallo, et al.
Published: (2022-06-01)

Myxofibrosarcoma - Case report
by: Breno Augusto Campos de Castro, et al.
Published: (2016-02-01)

Myxofibrosarcoma of the Maxillary Sinus
by: Anni Wong B.A.,M.S., et al.
Published: (2017-06-01)

Editorial: The immune infiltrate as a paradigm model to study the biology and novel therapeutic approaches in sarcomas
by: Federica Recine, et al.
Published: (2023-12-01)

Distant metastasis in patients with myxofibrosarcoma
by: Hiroyuki Tsuchie, et al.
Published: (2017-07-01)

Clinicalopathological evaluation of soft tissue myxofibrosarcoma
by: Sevil Karabağ, et al.
Published: (2021-03-01)

Low grade mandibular myxofibrosarcoma in an adult
by: Carlos Juan Puig González, et al.
Published: (2022-05-01)

Primary myxofibrosarcoma of the parotid: case report
by: Qiao Li, et al.
Published: (2010-06-01)

Myxofibrosarcoma of the leg: A diagnostic challenge
by: Imène Rachdi, et al.
Published: (2020-12-01)

Mesenteric Myxofibrosarcoma: A Case Report
by: Kunihiro Ozaki, et al.
Published: (2020-07-01)

PROGNOSTIC FACTORS IN PATIENTS WITH APPENDICULAR MYXOFIBROSARCOMA
by: Juan Pablo Zumárraga, et al.
Published: (2018-10-01)

Integrated genetic and epigenetic analysis of myxofibrosarcoma
by: Koichi Ogura, et al.
Published: (2018-07-01)

Analysis of clinical factors impacting recurrence in myxofibrosarcoma
by: Wenlin Chen, et al.
Published: (2024-02-01)